D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.14% |
| 4 | Healthcare | 8% |
| 5 | Energy | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
OFG Bancorp
OFG
$2.21B
| $1.71M | ﹤0.01% |
64,030
-29,526
| -32% | -$820K |
|
3302
CALL
Perrigo
PRGO
$1.44B
| $1.71M | ﹤0.01% |
+44,400
| New | +$1.69M |
|
|
ONEM
3303
DELISTED
1Life Healthcare
ONEM
| $1.71M | ﹤0.01% |
+153,904
| New | +$1.72M |
|
|
TWOU
3304
CALL
DELISTED
2U Inc
TWOU
| $1.7M | ﹤0.01% |
4,270
-340
| -7% | -$137K |
|
3305
Ashland
ASH
$3.34B
| $1.7M | ﹤0.01% |
17,264
+7,735
| +81% | +$744K |
|
3306
Enovix
ENVX
$803M
| $1.7M | ﹤0.01% |
+136,102
| New | +$1.91M |
|
|
ZYXI
3307
DELISTED
Zynex
ZYXI
| $1.7M | ﹤0.01% |
272,526
+139,362
| +105% | +$979K |
|
|
GRIN
3308
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
| $1.7M | ﹤0.01% |
+66,749
| New | +$1.38M |
|
|
IBER
3309
DELISTED
Ibere Pharmaceuticals
IBER
| $1.7M | ﹤0.01% |
172,962
-231,214
| -57% | -$2.25M |
|
3310
PUT
Magna International
MGA
$18.8B
| $1.69M | ﹤0.01% |
+26,300
| New | +$1.95M |
|
3311
L3Harris
LHX
$55.4B
| $1.69M | ﹤0.01% |
6,801
-106,509
| -94% | -$24.8M |
|
|
BNIX
3312
DELISTED
Bannix Acquisition Corp. Common Stock
BNIX
| $1.69M | ﹤0.01% |
170,775
+378
| +0.2% | +$3.73K |
|
3313
CALL
Choice Hotels
CHH
$5.26B
| $1.69M | ﹤0.01% |
11,900
| – | – |
|
|
LHCG
3314
CALL
DELISTED
LHC Group LLC
LHCG
| $1.69M | ﹤0.01% |
10,000
| – | – |
|
|
LHCG
3315
PUT
DELISTED
LHC Group LLC
LHCG
| $1.69M | ﹤0.01% |
10,000
| – | – |
|
3316
OSI Systems
OSIS
$3.53B
| $1.68M | ﹤0.01% |
19,726
+103
| +0.5% | +$8.66K |
|
|
APLS
3317
DELISTED
Apellis Pharmaceuticals
APLS
| $1.68M | ﹤0.01% |
33,034
-4,856
| -13% | -$214K |
|
3318
Enova International
ENVA
$6.09B
| $1.68M | ﹤0.01% |
44,159
-2,211
| -5% | -$88.8K |
|
3319
Advanced Drainage Systems
WMS
$10.6B
| $1.68M | ﹤0.01% |
14,106
-23,102
| -62% | -$2.74M |
|
|
CSGS
3320
DELISTED
CSG Systems International
CSGS
| $1.68M | ﹤0.01% |
26,342
-10,806
| -29% | -$650K |
|
|
WNNR.U
3321
DELISTED
Andretti Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable public warrant
WNNR.U
| $1.68M | ﹤0.01% |
+166,667
| New | +$1.67M |
|
|
AFAQ
3322
DELISTED
AF Acquisition Corp
AFAQ
| $1.67M | ﹤0.01% |
171,689
-426,297
| -71% | -$4.14M |
|
3323
Aterian
ATER
$4.07M
| $1.67M | ﹤0.01% |
+57,359
| New | +$2.1M |
|
3324
Deluxe
DLX
$1.25B
| $1.67M | ﹤0.01% |
55,306
+3,418
| +7% | +$107K |
|
3325
Caleres
CAL
$432M
| $1.67M | ﹤0.01% |
86,279
-1,492
| -2% | -$32.3K |
|
Similar funds
D.E. Shaw & Co's Q1 2022 Portfolio in Review
As of Q1 2022, D.E. Shaw & Co held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
D.E. Shaw & Co withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Cenovus Energy worth $141M.
- D.E. Shaw & Co's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- D.E. Shaw & Co added most to Starbucks in Q1 2022, an estimated $384M increase.
- D.E. Shaw & Co's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- D.E. Shaw & Co's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- D.E. Shaw & Co opened 934 new positions and closed 805 in Q1 2022.
- D.E. Shaw & Co's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.